Home | Forum | Search
Juvenile Arthritis
by Food and Drug Administration (FDA)

(Page 5 of 5)

Nearly 300,000 children in the United States have a form of juvenile arthritis or a rheumatic disease that occurs before age 16. The most common form in children is juvenile rheumatoid arthritis. The cause of most forms of juvenile arthritis remains unknown. Juvenile arthritis is not contagious, and there is no evidence that foods, toxins, allergies, or vitamin deficiencies play a role. Current research indicates that there may be a genetic predisposition to juvenile arthritis. In other words, the combination of genes a child inherits may contribute to the development of arthritis when combined with other undefined factors. Most of the symptoms of juvenile arthritis are due to inflammation as a result of imbalances in the immune system. Despite not knowing the exact cause or causes, there are many effective treatments available to help children and their parents manage juvenile arthritis. Experts say that most children with arthritis can expect to live normal lives.

The Future

Many government and private organizations are working together to carry out a plan to guide the use of the nation's resources to decrease the burden of arthritis for all Americans and increase the quality of life of those affected by arthritis. Called the "National Arthritis Action Plan: A Public Health Strategy," it provides a blueprint for reducing pain, activity limitations, and disability among people with arthritis, as well as for preventing certain types of arthritis.

As for the safety of future arthritis treatments, experience has shown that the full magnitude of some potential risks of all drugs has not always emerged during the mandatory safety and effectiveness studies conducted before the FDA can approve a drug. As always, the agency advises physicians to consider the evolving information on any medication in evaluating the risks and benefits of these drugs in individual patients.

"The outlook for people with arthritis has never been more hopeful," adds Birbara.

Other Common Rheumatic Conditions

Fibromyalgia — a chronic disorder that causes pain throughout the tissues that support and move the bones and joints. Pain, stiffness, and localized tender points occur in the muscles and tendons, particularly those of the neck, spine, shoulders, and hips. Patients also may experience fatigue and sleep disturbances.

Systemic lupus erythematosus (lupus or SLE) — an autoimmune disease in which the immune system harms the body's own healthy cells and tissues. This can result in inflammation of and damage to the joints, skin, kidneys, heart, lungs, blood vessels, and brain.

Scleroderma (systemic sclerosis) — affects the skin, blood vessels, and joints and literally means "hard skin." It may also affect internal organs, such as the lungs and kidneys. There is an abnormal and excessive production of a fiber-like protein called collagen in the skin or internal organs.

Spondyloarthropathies — a group of rheumatic diseases principally affecting the spine. One common form — ankylosing spondylitis — may also affect the hips, shoulders, and knees as the tendons and ligaments around the bones and joints become inflamed, resulting in pain and stiffness. Another form — reactive arthritis or Reiter's syndrome — develops after an infection involving the lower urinary tract, bowel, or other organ and is commonly associated with eye problems, skin rashes, and mouth sores.

Gout — results from deposits of needle-like crystals of uric acid in the joints. The crystals cause inflammation, swelling, and pain in the affected joint, which is often the big toe.

Infectious arthritis — caused by infectious agents, such as bacteria or viruses. Parvovirus arthritis and gonococcal arthritis are examples of infectious arthritis. Arthritis symptoms may also occur in Lyme disease, which is caused by a bacterial infection following the bite of certain ticks.

Psoriatic arthritis — occurs in some patients with psoriasis, a scaling skin disorder. This form often affects the joints at the ends of the fingers and toes and is accompanied by changes in the fingernails and toenails. Back pain may occur if the spine is involved.

Bursitis — involves inflammation of the bursae, small, fluid-filled sacs that help reduce friction between bones and other moving structures in the joints. The inflammation may result from arthritis in the joint or injury or infection of the bursae. Bursitis produces pain and tenderness and may limit the movement of nearby joints.

« Previous  


About the Author

www.fda.gov
FDA is A United States government body that oversees medical devices, including contact lenses, intraocular lenses, excimer lasers and eyedrops. In the US, these products must be approved by the FDA before they can be marketed.

  In this article
» Treatments Keep People With Arthritis Moving
» The Burden of Arthritis
» Arthritis and Rheumatic Conditions, Biologic Treatments
» Arthritis Treatment Devices, Diet and Exercise
» Juvenile Arthritis
Related Topics
Neurological Disorders
Eating Disorder
Hypertension
Articles & Books
Who Needs a Joint Replacement? - What Your Doctor May Not Tell You About Hip and Knee Replacement Surgery
There isn't as much deception with joint replacement surgery as there is with outpatient arthroscopies (see What Your Doctor May Not Tell You About Knee Pain and Surgery, Warner Books, 2002). If your doctor has suggested a joint replacement
Arthritis: Modern Treatments for That Old Pain in the Joints
Modern drug treatment and joint replacement are helping to minimize the effects of arthritis, which, in its more than 100 different forms, affects about 50 million Americans with symptoms ranging from minor stiffness to complete disability.
Arthritis : Biologics Block Cytokines, Joint Replacement
Today, the first pharmaceutical line of defense against arthritis is the NSAIDs (nonsteroidal anti-inflammatory drugs), which include the salicylates, such as aspirin, prescribed at higher than usual doses.

© 2008 eNotAlone.com